Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terrence R Burke

Showing results (41-50 of 169) with videos related to

Pageof 17
Sort By:
Bioorganic & Medicinal Chemistry Letters|November 20, 2012
Non-proteinogenic amino acids in the pThr-2 position of a pentamer peptide that confer high binding affinity for the polo box domain (PBD) of polo-like kinase 1 (Plk1)Wen-Jian Qian, Jung-Eun Park, Kyung S Lee, et al.
Retrovirology|May 18, 2018
Efficacies of Cabotegravir and Bictegravir against drug-resistant HIV-1 integrase mutantsSteven J Smith, Xue Zhi Zhao, Terrence R Burke, et al.
Chemistry & Biodiversity|May 16, 2014
Design and synthesis of Fmoc-Thr[PO(OH)(OPOM)] for the preparation of peptide prodrugs containing phosphothreonine in fully protected formWen-Jian Qian, Christopher C Lai, James A Kelley, et al.
Antimicrobial Agents and Chemotherapy|July 11, 2018
HIV-1 Integrase Inhibitors That Are Broadly Effective against Drug-Resistant MutantsSteven J Smith, Xue Zhi Zhao, Terrence R Burke, et al.
Frontiers in Immunology|September 10, 2019
Conventional and Chemically Programmed Asymmetric Bispecific Antibodies Targeting Folate Receptor 1Junpeng Qi, David Hymel, Christopher G Nelson, et al.
Bioorganic & Medicinal Chemistry Letters|September 10, 2002
Development of a phosphatase-stable phosphotyrosyl mimetic suitably protected for the synthesis of high-affinity Grb2 SH2 domain-binding ligandsChang-Qing Wei, Bihua Li, Ribo Guo, et al.
RSC Chemical Biology|September 21, 2022
Development of ultra-high affinity bivalent ligands targeting the polo-like kinase 1Kohei Tsuji, David Hymel, Buyong Ma, et al.
Bioorganic & Medicinal Chemistry Letters|September 4, 2018
Histidine N(τ)-cyclized macrocycles as a new genre of polo-like kinase 1 polo-box domain-binding inhibitorsDavid Hymel, Robert A Grant, Kohei Tsuji, et al.
Anti-Cancer Drugs|December 1, 2005
Molecular targeting of growth factor receptor-bound 2 (Grb2) as an anti-cancer strategyPathirage G Dharmawardana, Benedetta Peruzzi, Alessio Giubellino, et al.
Journal of Biomolecular NMR|September 20, 2011
An NMR strategy for fragment-based ligand screening utilizing a paramagnetic lanthanide probeTomohide Saio, Kenji Ogura, Kazumi Shimizu, et al.
Pageof 17

Showing results (41-50 of 169) with videos related to

Sort By:
Pageof 17
Bioorganic & Medicinal Chemistry Letters|November 20, 2012
Non-proteinogenic amino acids in the pThr-2 position of a pentamer peptide that confer high binding affinity for the polo box domain (PBD) of polo-like kinase 1 (Plk1)Wen-Jian Qian, Jung-Eun Park, Kyung S Lee, et al.
Retrovirology|May 18, 2018
Efficacies of Cabotegravir and Bictegravir against drug-resistant HIV-1 integrase mutantsSteven J Smith, Xue Zhi Zhao, Terrence R Burke, et al.
Chemistry & Biodiversity|May 16, 2014
Design and synthesis of Fmoc-Thr[PO(OH)(OPOM)] for the preparation of peptide prodrugs containing phosphothreonine in fully protected formWen-Jian Qian, Christopher C Lai, James A Kelley, et al.
Antimicrobial Agents and Chemotherapy|July 11, 2018
HIV-1 Integrase Inhibitors That Are Broadly Effective against Drug-Resistant MutantsSteven J Smith, Xue Zhi Zhao, Terrence R Burke, et al.
Frontiers in Immunology|September 10, 2019
Conventional and Chemically Programmed Asymmetric Bispecific Antibodies Targeting Folate Receptor 1Junpeng Qi, David Hymel, Christopher G Nelson, et al.
Bioorganic & Medicinal Chemistry Letters|September 10, 2002
Development of a phosphatase-stable phosphotyrosyl mimetic suitably protected for the synthesis of high-affinity Grb2 SH2 domain-binding ligandsChang-Qing Wei, Bihua Li, Ribo Guo, et al.
RSC Chemical Biology|September 21, 2022
Development of ultra-high affinity bivalent ligands targeting the polo-like kinase 1Kohei Tsuji, David Hymel, Buyong Ma, et al.
Bioorganic & Medicinal Chemistry Letters|September 4, 2018
Histidine N(τ)-cyclized macrocycles as a new genre of polo-like kinase 1 polo-box domain-binding inhibitorsDavid Hymel, Robert A Grant, Kohei Tsuji, et al.
Anti-Cancer Drugs|December 1, 2005
Molecular targeting of growth factor receptor-bound 2 (Grb2) as an anti-cancer strategyPathirage G Dharmawardana, Benedetta Peruzzi, Alessio Giubellino, et al.
Journal of Biomolecular NMR|September 20, 2011
An NMR strategy for fragment-based ligand screening utilizing a paramagnetic lanthanide probeTomohide Saio, Kenji Ogura, Kazumi Shimizu, et al.
Pageof 17